Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis

Yen-Nien Liu1, JuanJuan Yin2, Ben Barrett2

  • 1Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan liuy@tmu.edu.tw kellyka@mail.nih.gov.

Insights

Loss of microRNA 1 (miR-1) in prostate cancer promotes bone metastasis by increasing SRC expression. This regulatory network involves the androgen receptor (AR), linking low AR activity to cancer spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Bone metastasis is a critical hallmark of advanced prostate cancer, particularly castration-resistant prostate cancer.
  • Decreased levels of microRNA 1 (miR-1) are observed in primary prostate cancer and are further reduced in metastatic samples.
  • SRC signaling is implicated in bone metastasis, but its precise regulation by microRNAs in this context is not fully understood.

Purpose of the Study:

  • To elucidate the role of miR-1 in prostate cancer bone metastasis.
  • To investigate the regulatory relationship between miR-1, SRC, and the androgen receptor (AR) in prostate cancer progression.

Main Methods:

  • Analysis of clinical prostate cancer samples to correlate miR-1 levels with SRC expression and AR activity.
  • In vitro studies using prostate cancer cell lines to assess the functional impact of miR-1 and SRC.
  • Xenograft mouse models to evaluate the effect of miR-1 on bone metastasis and extracellular signal-regulated kinase (ERK) signaling.

Main Results:

  • SRC was identified as a direct target of miR-1, with inverse correlation observed between miR-1 and SRC expression in patient samples.
  • Ectopic miR-1 expression suppressed ERK signaling and bone metastasis in vivo.
  • Androgen receptor (AR) directly binds to and regulates miR-1 transcription, with low miR-1 levels correlating with low AR gene signatures in patients.

Conclusions:

  • A regulatory network involving AR, miR-1, and SRC is proposed to be crucial in prostate cancer bone metastasis.
  • Loss of miR-1 represents a mechanistic link between reduced AR activity and SRC-driven metastatic phenotypes in castration-resistant prostate cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K